Trulieve Cannabis Corp. (OTCMKTS:TCNNF – Get Free Report) was the recipient of a large decline in short interest in May. As of May 15th, there was short interest totaling 243,173 shares, a decline of 64.0% from the April 30th total of 674,961 shares. Based on an average daily volume of 799,789 shares, the days-to-cover ratio is presently 0.3 days.
Analyst Ratings Changes
Separately, Alliance Global Partners reissued a “buy” rating on shares of Trulieve Cannabis in a research report on Thursday, May 7th. One investment analyst has rated the stock with a Buy rating, Based on data from MarketBeat.com, Trulieve Cannabis has a consensus rating of “Buy”.
Check Out Our Latest Research Report on Trulieve Cannabis
Trulieve Cannabis Stock Down 4.0%
Trulieve Cannabis Company Profile
Trulieve Cannabis Corp. is a vertically integrated cannabis operator and retailer, offering a full suite of services from cultivation and processing to distribution and sales. The company develops, manufactures and markets a diverse range of cannabis products under its own brand portfolio, serving both medical and adult-use consumers through a network of branded dispensaries and delivery services.
Trulieve’s product lineup includes dried flower, vape cartridges, concentrates, edibles, tinctures and topicals, all of which are produced in compliance with state regulatory requirements.
Read More
- Five stocks we like better than Trulieve Cannabis
- Shares Fall, Targets Rise—Markets and Analysts Diverge on Synopsys
- Salesforce Stock Finds Support as AI Momentum Builds
- Dollar Tree Keeps Winning After Family Dollar Divorce
- Apple’s Agentic AI Plans Could Be Its Biggest Growth Story Yet
Receive News & Ratings for Trulieve Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trulieve Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.
